Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Deshi Shi
Carboxylesterase-2 Is a Highly Sensitive Target of the Antiobesity Agent Orlistat With Profound Implications in the Activation of Anticancer Prodrugs
Biochemical Pharmacology
Biochemistry
Pharmacology
Related publications
Multiplicity of Carboxylesterase Isozymes in Mammals and Humans: Role in Metabolic Activation of Prodrugs
Drug Metabolism and Pharmacokinetics
Organ-Specific Carboxylesterase Profiling Identifies the Small Intestine and Kidney as Major Contributors of Activation of the Anticancer Prodrug CPT-11
Biochemical Pharmacology
Biochemistry
Pharmacology
Diacetoxyscirpenol as a New Anticancer Agent to Target Hypoxia-Inducible Factor 1
Oncotarget
Oncology
Oncogenic microRNA-27a Is a Target for Anticancer Agent Methyl 2-Cyano-3,11-Dioxo-18β-Olean-1,12-Dien-30-Oate in Colon Cancer Cells
International Journal of Cancer
Cancer Research
Oncology
Carboxylesterase Isoform 2 mRNA Expression in Peripheral Blood Mononuclear Cells Is a Predictive Marker of the Irinotecan to SN38 Activation Step in Colorectal Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
Garcinia Cambogia (Hydroxycitric Acid) as a Potential Antiobesity Agent
JAMA - Journal of the American Medical Association
Medicine
Sacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
Biological Evidences of Hepatocellular Carcinoma Treatment With 1,3,4-Oxadiazole-2-Thiol as Anticancer Agent
Journal of Biomolecular Research & Therapeutics
Repurposing the Serotonin Agonist Tegaserod as an Anticancer Agent in Melanoma: Molecular Mechanisms and Clinical Implications
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
